Ignite Creation Date:
2024-05-06 @ 3:22 PM
Last Modification Date:
2024-10-26 @ 1:48 PM
Study NCT ID:
NCT04614636
Status:
TERMINATED
Last Update Posted:
2023-09-21
First Post:
2020-10-29
Brief Title:
FT538 in Subjects With Advanced Hematologic Malignancies
Sponsor:
Fate Therapeutics
Organization:
Fate Therapeutics
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Myeloma |
| Acute Myeloid Leukemia |
| AML Adult |
| Multiple Myeloma |